Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Ball

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|March 3, 2020
Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal AllograftsKin Yee Shiu, Dominic Stringer, Laura McLaughlin, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 3, 2002
A new mouse mutant, skijumperMajid Hafezparast, Simon Ball, Sharon J Nicholson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 TrialMakoto Nishio, Fabrice Barlesi, Howard West, et al.
Dementia (London, England)|October 31, 2018
Contributions of patient and citizen researchers to 'Am I the right way up?' study of balance in posterior cortical atrophy and typical Alzheimer's diseaseSebastian J Crutch, Keir Xx Yong, Amy Peters, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Heart (British Cardiac Society)|October 6, 2020
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UKSimon Ball, Amitava Banerjee, Colin Berry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerSteven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
Science (New York, N.Y.)|May 6, 2003
Mutations in dynein link motor neuron degeneration to defects in retrograde transportMajid Hafezparast, Rainer Klocke, Christiana Ruhrberg, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|March 3, 2020
Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal AllograftsKin Yee Shiu, Dominic Stringer, Laura McLaughlin, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 3, 2002
A new mouse mutant, skijumperMajid Hafezparast, Simon Ball, Sharon J Nicholson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKDMartin Landray, Colin Baigent, Craig Leaper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 TrialMakoto Nishio, Fabrice Barlesi, Howard West, et al.
Dementia (London, England)|October 31, 2018
Contributions of patient and citizen researchers to 'Am I the right way up?' study of balance in posterior cortical atrophy and typical Alzheimer's diseaseSebastian J Crutch, Keir Xx Yong, Amy Peters, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Heart (British Cardiac Society)|October 6, 2020
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UKSimon Ball, Amitava Banerjee, Colin Berry, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerSteven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
Science (New York, N.Y.)|May 6, 2003
Mutations in dynein link motor neuron degeneration to defects in retrograde transportMajid Hafezparast, Rainer Klocke, Christiana Ruhrberg, et al.
Pageof 10